# IGF::OT::IGF IMMUNOGENICITY OF NONAVALENT HPV VACCINE ADMINISTERED PRIOR TO LIVING DONOR RENAL TRANSPLANTATION  IN ADULT WOMEN:  A PROSPECTIVE, SINGLE-ARM, MULTI-CENTER CLINICAL TRIAL

> **NIH NIH N01** · NORTHWESTERN UNIVERSITY · 2021 · $31,613

## Abstract

The contractor will conduct a prospective single-arm trial to evaluate if the nonavalent HPV Gardasil 9 HPV vaccine induces and sustains an adequate immune response at 12-months post-transplantation among 18-49 years old female living donor kidney transplant recipients when ≥ 1 doses of the vaccine are administered ≥ 30 days prior to transplantation.

## Key facts

- **NIH application ID:** 10487381
- **Project number:** 261201200035I-P00002-26100010-1
- **Recipient organization:** NORTHWESTERN UNIVERSITY
- **Principal Investigator:** SEEMA KHAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $31,613
- **Award type:** —
- **Project period:** 2016-09-15 → 2023-09-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10487381

## Citation

> US National Institutes of Health, RePORTER application 10487381, IGF::OT::IGF IMMUNOGENICITY OF NONAVALENT HPV VACCINE ADMINISTERED PRIOR TO LIVING DONOR RENAL TRANSPLANTATION  IN ADULT WOMEN:  A PROSPECTIVE, SINGLE-ARM, MULTI-CENTER CLINICAL TRIAL (261201200035I-P00002-26100010-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10487381. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*